TIME FOR A EUROPEAN ORPHAN DRUGS POLICY

被引:0
|
作者
LEBLOND, D
机构
来源
EUROPEAN CHEMICAL NEWS | 1995年 / 63卷 / 1652期
关键词
D O I
暂无
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Europe lags behind the US and Japan in the development of orphan drugs - defined as drugs for rare and tropical diseases - but a new report has proposals for putting it on a more equal footing. It suggests the establishment of a defined status for orphan drugs, to help this commercialisation.
引用
收藏
页码:17 / 17
页数:1
相关论文
共 50 条
  • [21] Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries
    Stawowczyk, Ewa
    Malinowski, Krzysztof Piotr
    Kawalec, Pawel
    Bobinski, Rafal
    Siwiec, Jacek
    Panteli, Dimitra
    Eckhardt, Helene
    Simoens, Steven
    Agusti, Antonia
    Dooms, Marc
    Pilc, Andrzej
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [22] ANALYSIS OF ORPHAN DRUGS REIMBURSEMENT IN MAJOR EUROPEAN HTA AGENCIES
    Houzelot, D.
    Heng, C.
    Perinaud, A.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A602 - A602
  • [23] Orphan drugs: European Union priorities for research and regulatory actions
    Fracchia, GN
    Haavisto, KH
    [J]. EUROPEAN MEDICINES RESEARCH: PERSPECTIVES IN CLINICAL TRIALS, 1996, : 15 - 20
  • [24] Orphan drugs and orphan diseases
    Campos-Castelló, J
    [J]. REVISTA DE NEUROLOGIA, 2001, 33 (03) : 216 - 220
  • [25] TIME FOR REIMBURSEMENT FOR ORPHAN DRUGS IN EU5
    Prada, M.
    Berard, I
    Walzer, S.
    Darba, J.
    Greenwood, B.
    [J]. VALUE IN HEALTH, 2018, 21 : S264 - S264
  • [26] ORPHAN DRUGS
    LYLE, WH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (15): : 813 - 814
  • [27] ORPHAN DRUGS
    BLANCHARD, T
    [J]. NATURE, 1992, 358 (6387) : 534 - 534
  • [28] Orphan drugs
    Messori, Andrea
    Attanasio, Francesco
    Trippoli, Sabrina
    Banfi, Roberto
    [J]. LANCET, 2019, 393 (10181): : 1595 - 1595
  • [29] Orphan drugs
    Burke, Maria
    [J]. CHEMISTRY & INDUSTRY, 2013, 77 (09) : 38 - 41
  • [30] ORPHAN DRUGS
    SCHIFFRIN, MJ
    [J]. ANNALS OF ALLERGY, 1982, 48 (01): : 63 - 65